New chemo cocktail shows promise for rare bone cancer
NCT ID NCT03011528
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a more intense chemotherapy plan for people aged 2 to 50 with Ewing sarcoma that has spread beyond the lungs. The goal was to see if this approach could help more patients become cancer-free for at least 18 months. The treatment combined high-dose chemotherapy with a stem cell transplant to try to control the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EWING SARCOMA FAMILY OF TUMORS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bordeaux Chu
Bordeaux, 33076, France
-
CHRU Montpellier - Hôpital A. de Villeneuve
Montpellier, 34295, France
-
CHU Grenoble Alpes
Grenoble, 38043, France
-
CHU Hôpital Sud
Rennes, 35056, France
-
Chr Felix Guyon
La Réunion, Saint Denis, 97400, France
-
LILLE Centre Oscar Lambret
Lille, 59000, France
-
LYON Centre Léon Bérard
Lyon, 69000, France
-
Marseille Chu
Marseille, 13000, France
-
NANCY Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, 54519, France
-
Nancy Chu
Vandœuvre-lès-Nancy, 54511, France
-
Nantes Chu
Nantes, 44000, France
-
PARIS Institut Curie
Paris, 75005, France
-
PARIS Trousseau
Paris, 75012, France
-
Strasbourg Chu
Strasbourg, 67098, France
-
TOULOUSE Institut Claudius Regaud
Toulouse, 31059, France
-
Toulouse Chu
Toulouse, 31059, France
-
VILLEJUIF Institut Gustave Roussy
Villejuif, 94805, France